Ended down[Cry] 

Superficially does seem like Pfizer’s new drug is superior. ”Only about 0.8% of patients who received Paxlovid were hospitalized through day 28 compared to 7% of patients who received placebo and were hospitalized or died.Merck reported that 7.3% of patients who received molnupiravir were either hospitalized or died through day 29 compared with 14.1% of placebo-treated patients.”Looking at the above figures, about double of those who received placebo for Merck’s died compared to Pfizer. Does it mean that the patients recruited into Merck’s study are sicker? Without going into studying both trials in detail, suffice to say both appear to be efficacious but I’m not too sure if Pfizer’s is superior to Merck’s. 

Wow! More spending and hopefully will drivestock prices higher which will make the rich richer? A quick glance at the kind of social spending and it seems it is even more socialist than some countries? Hmmm…

Alt coins will follow?

11/11 is a great day for both e-commerce companies and related industries as well as consumers!